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Objectives: Childhood allergic diseases are a major concern because they lead to a heavy economic burden and poor quality of life. The
purpose of this study was to investigate the prevalence of childhood atopic dermatitis, asthma, allergic rhinitis, and the comorbidity of
allergic diseases in Seoul, Korea.
Methods: We conducted a cross-sectional survey between May and October 2010 to evaluate the prevalence of childhood allergic diseases,
including atopic dermatitis, asthma, and allergic rhinitis, using a questionnaire from the International Study of Asthma and Allergies in
Childhood group. Each questionnaire was completed by the parent or guardian of a child.
Results: In the 31,201 children studied, the prevalence of atopic dermatitis symptoms in the past 12 months was 19.3% in children 0 to 3
years of age, 19.7% in children 4 to 6 years of age, 16.7% in children 7 to 9 years of age, and 14.5% in children 10 to 13 years of age (p for
trend < 0.001). The prevalence of asthma in these age groups was 16.5%, 9.8%, 6.5%, and 5.4%, respectively (p for trend < 0.001). The
prevalence of allergic rhinitis in these age groups was 28.5%, 38.0%, 38.5%, and 35.9%, respectively (pfor trend = 0.043). The percentage of
subjects with both atopic dermatitis and asthma, both asthma and allergic rhinitis, or both atopic dermatitis and allergic rhinitis was 2.5%,
4.7%, and 8.7%, respectively. The prevalence of comorbid allergic diseases decreased with age (pfor trend < 0.001).
Conclusions: Our study revealed that the prevalence of some allergic diseases, such as atopic dermatitis and asthma, was relatively high in
very young children and that all of the principal allergic diseases in children often co-exist.
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INTRODUCTION
Atopic dermatitis, asthma, and allergic rhinitis are chronic
diseases that are common in infants [1,2], and the allergic
disease prevalence in Korea has been consistently increasing
[3, 4]. The increase in allergic diseases has been an
important public health problem in society because these
diseases cause sleep disorders, impede growth, disrupt
education [5,6], and significantly increase the socioeconomic
burden by lowering the quality of life for the family [7,8].
Because the prevalence of allergic diseases is closely
related to age and dependent on the type of allergic disease,
the symptoms manifest at different ages [9]. In foreign
studies evaluating the prevalence of allergic diseases in
children and infants, the rate of atopic dermatitis was highest
in children under 5 years of age, asthma symptoms were
highest in children between 2 and 9 years of age, and allergic
rhinitis was highest in those between 6 and 11 years of age
[10]. While research has been conducted in Korea to
evaluate allergic diseases in children, few studies have
evaluated the prevalence of allergic diseases before infancy.
According to the International Study of Asthma and
Allergies in Childhood (ISAAC) conducted by Oh et al. [4]
the prevalence of ‘atopic dermatitis symptoms during the
past 12 months’ for the year 2000 was 10.7% in children
between 6 and 12 years of age and 6.1% in those between 12
and 15 years of age, whereas the prevalence of ‘atopic
dermatitis symptoms during the past 12 months’ for the year
2003 was highest in 5-year-old children, with a prevalence
rate of 21.1%. The second highest prevalence rate was found
in elementary and middle school students. After
investigating the prevalence of allergic diseases throughout
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Open AccessKorea among elementary school students, i.e., 3
rd, 4
th, and 5
th
grade students, using ‘symptoms of the past 12 months’ as a
standard, Suh et al. [11] determined the prevalence of atopic
dermatitis, asthma, and allergic rhinitis to be 15.3%, 4.8%,
and 32.9%, respectively. Kwon et al. [12] analyzed
elementary school students in the region of Seoul in 2008
and determined the prevalence of asthma symptoms to be
5.5%, whereas the prevalence of asthma treatment had been
2.7% during the previous 12 months.
There have been several epidemiological studies
evaluating the prevalence of allergic diseases in Korea, but
due to variations in the diseases studied, the starting point of
the investigations, and the age of the subjects, we were
unable to perform systematic comparisons to determine
changes in prevalence according to age. Nonetheless,
because allergic diseases have a number of symptoms that
are expressed differently according to age, the effective
management of allergic symptoms requires a better
understanding of the prevalence of these diseases during
infancy.
Because the existence of subjects with multiple allergic
reactions (i.e., multiple allergic diseases) is not rare, a patient
with one allergic disease has an increased probability of
developing another allergic disease [13]. For example, atopic
dermatitis is an important risk factor in the development of
additional allergic reactions [14]. In research performed in
Beijing on subjects between 0 and 14 years of age, the
percentage of children with asthma who were also suffering
from dermatitis was 45.2%, the percentage of children with
asthma who were also suffering from allergic rhinitis was
49.5%, and the percentage of children with both asthma and
dermatitis was 23.1% [10]. Allergic diseases may manifest
themselves by demonstrating aspects of multiple allergic
diseases where many symptoms appear together, but there
are very few studies on multiple allergic diseases in Korea.
The purpose of the present study was to determine the
prevalence of individual allergic diseases and of multiple
allergic diseases based on child subjects between the ages of
0 and 13 years.
MATERIALS AND METHODS
I. Subjects and Design
This study enrolled 38,201 children between 0 and 13
years of age from 34 elementary schools and 136 children’s
daycare centers to participate in the ‘Seoul Atopy Friendly
School’ survey from May to October 2010. Elementary
schools from 19 out of 25 districts (excluding Nowon,
Mapo, Yangchun, Dongjak, and Seocho) and children’s
daycare centers from 21 districts (excluding Jongno,
Gangbuk, Dobong, and Gangnam) participated in the  Seoul
Atopy Friendly School’ survey.
II. Questionnaire
The questionnaire gathered basic personal data and
information related to the prevalence of allergic diseases for
each subject. Because the clinical manifestations of allergic
diseases vary, prevalence can be demonstrated differently
depending on how the disease is defined. However, it is
possible to assess and compare the prevalence of allergic
diseases across the world using the ISAAC questionnaire
[15]. The prevalence indices for atopic dermatitis, asthma,
and allergic rhinitis used were ‘symptoms in the past 12
months’ and ‘experience of treatment in the past 12 months’.
For atopic dermatitis, a question such as,  Has your child
had an itchy rash at any time in the past 12 months?’ was
asked. If the response was ‘Yes’, it was counted toward ‘the
prevalence of atopic dermatitis symptom in the past 12
months’. A question such as, ‘Has your child been treated
for eczema in the past 12 months (congenital fever or atopic
dermatitis)?’ was then asked. If the response was ‘Yes’, it
was counted toward ‘the experience of treatment for atopic
dermatitis in the past 12 months’. For asthma, a question
such as, ‘Has your child had wheezing or whistling in the
chest in the past 12 months?’ was asked. If the response was
‘Yes’, it was counted toward ‘the prevalence of asthma
symptom in the past 12 months’. A question such as, ‘Has
your child ever been diagnosed and treated for asthma in the
past 12 months?’ was then asked. If the response was ‘Yes’,
it was counted toward ‘the experience of treatment for
asthma in the past 12 months’. For allergic rhinitis, a
question such as, ‘In the past 12 months, have you had a
problem with sneezing or a runny or blocked nose when you
did not have a cold or the flu?’ was asked. If the response
was ‘Yes’, it was counted toward ‘the prevalence of allergic
rhinitis symptom in the past 12 months’. A question such as,
‘Has your child ever been treated for allergic rhinitis in the
past 12 months?’ was asked. If the response was ‘Yes’, it
was counted toward ‘the experience of treatment for allergic
rhinitis in the past 12 months’.
III. Statistical Analysis
All of the statistical data were calculated using STATA
version 10.0 (StataCorp, College Station, TX, USA). The
general characteristics of the subjects are presented as the
means standard deviations for continuous variables and as
frequencies for categorical variables. A cross-analysis of the
subject’s age and allergic disease was implemented. To
calculate a trend in the prevalence of allergic diseases
according to age, a general linear model was implemented.
In all the analyses, a p-value <0.05 was regarded as
statistically significant.
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I. General Characteristics
Twenty-five districts in the capital, Seoul, were divided
according to their location, and 5 adjacent districts were
combined for the analysis. The distribution of the subjects is
presented in Table 1. For the first area (Jongno, Jung,
Yongsan, Seongdong, and Gwangjin), 7,015 children from
10 elementary schools and 22 children’s daycare centers
participated in the study. The second area (Dongdaemun,
Jungnang, Seongbuk, Gangbuk, and Dobong) included
6,010 children from 5 elementary schools and 29 children’s
daycare centers. For the third area (Nowon, Eunpyeong,
Seodaemun, Mapo, and Yangcheon), 4,242 children from 4
elementary schools and 33 children’s daycare centers
participated in the study. The fourth area (Gangseo, Guro,
Geimcheon, Yeongdeungpo, and Dongjak) included 4,512
children from 4 elementary schools and 33 children’s daycare
centers. Finally, the fifth area (Gwanak, Seocho, Gangnam,
Songpa, and Gangdong) included 9,422 children from 11
elementary schools and 32 children’s daycare centers. A total
of 31,361 subjects (82.1%) responded to the questionnaire,
but only the data from the 31,201 subjects without missing
information were analyzed. Out of a total of 170 Atopy
Friendly Schools, 34 elementary schools (20.0%), 136
children’s daycare centers (80.0%), 24,240 elementary
school students (77.7%), and 6,961 toddlers (22.3%) were
studied. Out of the 31,201 subjects, 51.1% were male, and
the ages ranged from 0 to 13 years (Table 2). Out of all of
the subjects, the children aged 10 to 13 years made up the
majority (38.2%). Children aged 7 to 9 years comprised
35.3% of the total study population, children aged 4 to 6
years comprised 16.9%, and children aged 0 to 3 years
comprised 9.6%.
II. Symptom Prevalence of Allergic Diseases and
Experience of Treatment
In Table 3, ‘symptom prevalence of atopic dermatitis,
asthma and allergic rhinitis in the past 12 months’ and
‘experience of treatment for atopic diseases in the past 12
months’ by age and gender are reported. The table shows
that the prevalence of atopic dermatitis symptoms in the past
12 months was 16.6% on average (19.3%, 19.7%, 16.7%,
and 14.5% for children 0 to 3 years of age, 4 to 6 years of
age, 7 to 9 years of age, and 10 to 13 years of age,
respectively). The prevalence in male children was highest
for children between 0 and 3 years of age (21.1%), and the
prevalence in female children was highest for those between
4 and 6 years of age (20.9%). As the children became older,
the prevalence showed a tendency to decrease (p for trend
<0.001). The treatment frequency for atopic dermatitis in the
past 12 months was 13.3%, and it was highest for children
between 0 and 3 years of age (18.8%). 
The prevalence of asthma symptoms in the past 12 months
was 7.6% on average (16.5%, 9.8%, 6.5%, and 5.4% for 0-
to 3-year-old, 4- to 6-year-old, 7- to 9-year-old, and 10- to
13-year-old children, respectively). In all the age groups, the
prevalence was higher in male children than in female
children. The treatment frequency for asthma in the past 12
months was 3.4%. In children 0 to 3 years of age, the
treatment frequency was 4.1% (4.8% in males and 3.3% in
females).
The prevalence of allergic rhinitis symptoms in the past 12
months was 36.5% on average (28.5%, 38.0%, 38.5%, and
35.9% for children 0 to 3 years of age, 4 to 6 years of age, 7
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Table 1.Regional distribution of subjects
Elementary school Day care center Total
Primary school
children
Preschool 
children
Total
Area 1
a
Area 2
b
Area 3
c
Area 4
d
Area 5
e
Total
Values are presented as number (%).
aArea1, Jongno, Jung, Yongsan, Seongdong, Gwangjin. 
bArea2, Dongdaemun, Jungnang, Seongbuk, Gangbuk, Dobong. 
cArea3, Nowon, Eunpyeong, Seodarmun, Mapo, Yangcheon. 
dArea4, Gangseo, Guro, Geimcheon, Yeongdeungpo, Dongjak. 
eArea5, Gwanak, Seocho, Gangnam, Songpa, Gangdong.
10
5
4
4
11
34
(32.3)
(16.1)
(12.9)
(12.9)
(35.5)
(20.0)
22
29
20
33
32
136
(16.2)
(21.3)
(14.7)
(24.3)
(23.5)
(80.0)
32
34
24
37
43
170
(18.8)
(20.0)
(14.1)
(21.8)
(25.3)
(100.0)
5,543
4,804
3,033
3,187
7,673
24,240
(22.9)
(19.8)
(12.5)
(13.1)
(31.7)
(77.7)
1,472
1,206
1,209
1,325
1,749
6,961
(21.1)
(17.3)
(17.4)
(19.0)
(25.1)
(22.3)
7,015
6,010
4,242
4,512
9,422
31,201
(22.5)
(19.3)
(13.6)
(14.5)
(30.2)
(100.0)
Table 2.Gender and age distribution of the subjects
n (%)
Gender
Male
Female
Age (y)
0 -   3
4 -   6 
7 -   9
10 - 13
15,922 (51.1)
15,279 (49.9)
03,006 (9.6)
05,258 (16.9)
11,017 (35.3)
11,920 (38.2)Environmental Health and Toxicology 2012;27:e2012006
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Table 4.Prevalence of comorbidity for atopic diseases and treatment frequency in the past 12 months
Symptom prevalence  Experience of treatment 
Total 
n  % (95% CI) n  % (95% CI) n  % (95% CI) n  % (95% CI) n  % (95% CI) n  % (95% CI)
Male Female Total Male Female
0 -   3 
4 -   6 
7 -   9 
10 - 13 
Total 
0 -   3 
4 -   6 
7 -   9 
10 - 13 
Total 
0 -   3 
4 -   6 
7 -   9 
10 - 13 
Total 
0 -   3 
4 -   6 
7 -   9 
10 - 13 
Total 
AD, atopic dermatitis; AR, allergic rhinitis; CI, confidence interval.
AD+Asthma 
pfor trend 
Asthma+AR
pfor trend 
AD+AR
pfor trend 
AD+Asthma+AR
pfor trend 
<0.001 
<0.001 
<0.001
<0.001 
<0.001 
<0.001 
0.005
<0.001 
<0.001 
<0.001 
<0.57
<0.001 
<0.053 
<0.001 
<0.08
<0.001 
0.34
0.73
0.22
0.81
0.19
0.28 
0.86
0.71
142 
174 
257 
210 
783 
222 
310 
495 
444 
1,471 
225 
535 
1,019 
924 
2,703 
82 
116 
193 
160 
551 
04.7 (4.0, 5.5) 
03.3 (2.8, 3.8) 
02.3 (2.0, 2.6) 
01.8 (1.5, 2.0) 
02.5 (2.3, 2.7) 
07.4 (6.5, 8.3) 
05.9 (5.3, 6.6) 
04.5 (4.1, 4.9) 
03.7 (3.4, 4.1) 
04.7 (4.4, 5.0) 
07.5 (6.5, 8.4) 
10.2 (9.4, 11.0) 
09.2 (8.7, 9.8) 
07.7 (7.2, 8.2) 
08.7 (8.3, 9.0) 
02.7 (2.1, 3.3) 
02.2 (1.8, 2.6) 
01.7 (1.5, 2.0) 
01.3 (1.2, 1.3) 
01.8 (1.6, 1.9) 
91 
101 
142 
133 
467 
142 
182 
319 
279 
922 
146 
280 
547 
493 
1,466 
56 
65 
119 
108 
348 
05.7 (4.6, 6.9) 
03.8 (3.1, 4.5) 
02.5 (2.1, 2.9) 
02.2 (1.8, 2.6) 
02.9 (2.7, 3.2) 
08.9 (7.5, 10.3) 
06.9 (5.9, 7.8) 
05.7 (5.1, 6.3) 
04.6 (4.1, 5.1) 
05.8 (5.4, 6.2) 
09.2 (7.7, 10.6) 
10.6 (9.4, 11.8) 
09.7 (8.9, 10.5) 
08.2 (7.5, 8.8) 
09.2 (8.8, 9.7) 
03.5 (2.6, 4.4) 
02.5 (1.9, 3.0) 
02.1 (1.7, 2.5) 
01.8 (1.5, 2.1) 
02.2 (2.0, 2.4) 
51 
73 
115 
77 
316 
80 
128 
176 
165 
549 
79 
255 
472 
430 
1,236 
26 
51 
74 
52 
203 
3.6 (2.6, 4.6) 
2.8 (2.2, 3.4) 
2.1 (1.8, 2.5) 
1.3 (1.0, 1.6) 
2.1 (1.8, 2.2) 
5.7 (4.5, 6.9) 
4.9 (4.1, 5.7) 
3.3 (2.8, 3.7) 
2.8 (2.4, 3.2) 
3.6 (3.2, 3.7) 
5.6 (4.4, 6.8) 
9.8 (8.6, 10.9) 
8.8 (8.0, 9.5) 
7.3 (6.7, 8.0) 
8.1 (7.3, 8.2) 
1.8 (1.1, 2.5) 
2.0 (1.4, 2.5) 
1.4 (1.1, 1.7) 
0.9 (0.6, 1.1) 
1.3 (1.1, 1.4) 
29 
54 
116 
92 
291 
38 
99 
233 
177 
547 
119 
242 
575 
479 
1,415 
12 
31 
74 
58 
175 
1.0 (0.6, 1.4) 
1.0 (0.8, 1.4) 
1.1 (0.8, 1.3) 
0.8 (0.6, 0.9) 
0.9 (0.8, 1.0) 
1.3 (0.9, 1.8) 
1.9 (1.5, 2.2) 
2.1 (1.8, 2.4) 
1.5 (1.3, 1.7) 
1.8 (1.6, 1.9) 
4.0 (3.2, 4.8) 
4.6 (4.1, 5.3) 
5.2 (4.7, 5.6) 
4.0 (3.7, 4.3) 
4.5 (4.3, 4.8) 
0.4 (0.2, 0.6) 
0.6 (0.4, 0.8) 
0.7 (0.5, 0.8) 
0.5 (0.4, 0.6) 
0.6 (0.5, 0.6) 
1.1 (0.6, 1.6) 
1.2 (0.8, 1.6) 
1.3 (1.0, 1.6) 
0.9 (0.7, 1.2) 
1.1 (1.0, 1.3) 
1.3 (0.7, 1.8) 
2.5 (1.9, 3.0) 
2.7 (2.3, 3.1) 
1.9 (1.6, 2.3) 
2.2 (2.0, 2.4) 
4.7 (3.7, 5.7) 
5.4 (4.6, 6.3) 
5.8 (5.2, 6.4) 
4.5 (4.0, 5.0) 
5.1 (4.8, 5.5) 
0.4 (0.1, 0.8) 
0.8 (0.4, 1.1) 
0.9 (0.6, 1.1) 
0.6 (0.4, 0.8) 
0.7 (0.6, 0.8) 
18 
31 
75 
57 
181 
20 
65 
151 
116 
352 
75 
144 
328 
272 
819 
7 
20 
48 
38 
113 
11 
23 
41 
35 
110 
18 
34 
82 
61 
195 
44 
97 
247 
206 
594 
5 
11 
26 
20 
62 
0.8 (0.3, 1.2) 
0.9 (0.5, 1.2) 
0.8 (0.5, 1.0) 
0.6 (0.4, 0.8) 
0.7 (0.6, 0.8) 
1.3 (0.7, 1.9) 
1.3 (0.9, 1.7) 
1.5 (1.2, 1.9) 
1.0 (0.8, 1.3) 
1.3 (1.1, 1.4) 
3.1 (2.2, 4.0) 
3.7 (3.0, 4.4) 
4.6 (4.0, 5.2) 
3.5 (3.0, 4.0) 
3.9 (3.4, 4.0) 
0.4 (0.1, 0.7) 
0.4 (0.2, 0.7) 
0.5 (0.3, 0.7) 
0.3 (0.2, 0.5) 
0.4 (0.3, 0.5) 
Table 3.Symptom prevalence of atopic diseases and treatment frequency in the past 12 months
Symptom prevalence  Experience of treatment 
Total 
n  % (95% CI) n  % (95% CI) n  % (95% CI) n  % (95% CI) n  % (95% CI) n  % (95% CI)
Male Female Total  Male Female
0  -  3 
4 -   6 
7 -   9 
10 - 13 
Total 
0  -  3 
4 -   6 
7 -   9 
10 - 13 
Total 
0  -  3 
4 -   6 
7 -   9 
10 - 13 
Total 
Atopic dermatitis
pfor trend 
Asthma 
pfor trend 
Allergic rhinitis
pfor trend 
<0.001
<0.001 
0.043  
<0.001
<0.001 
<0.001
<0.001
<0.001 
<0.001
<0.001
0.006 
<0.001
<0.001
0.002 
<0.001
<0.001
<0.001 
<0.001
325 
492 
910 
850 
2,577 
296 
295 
441 
393 
1,425 
513 
1,090 
2,413 
2,451 
6,467 
21.1 (18.4, 22.4) 
18.6 (17.1, 20.0) 
16.1 (15.2, 17.1) 
15.1 (13.1, 14.9) 
16.2 (15.6, 16.8) 
19.2 (16.7, 20.5) 
11.1 (9.9, 12.3) 
07.8 (7.1, 8.5) 
06.5 (5.8, 7.1) 
08.9 (8.5, 9.3) 
33.3 (29.9, 34.5) 
41.2 (39.3, 43.1) 
42.8 (39.3, 44.1) 
40.5 (39.3, 41.8) 
40.6 (39.9, 41.4) 
254 
546 
935 
875 
2,610 
201 
219 
281 
248 
949 
344 
910 
1,829 
1,825 
4,908 
18.0 (16.0, 20.0) 
20.9 (19.3, 22.5) 
17.4 (16.4, 18.4) 
14.9 (14.0, 15.8) 
16.4 (15.8, 17.0) 
14.2 (12.4, 16.0) 
08.4 (7.3, 9.4) 
05.2 (4.6, 5.8) 
04.6 (3.7, 4.7) 
06.0 (5.6, 6.3) 
24.3 (22.1, 26.6) 
34.8 (33.0, 36.7) 
34.0 (32.7, 35.3) 
31.1 (29.9, 32.3) 
30.8 (30.1, 31.5)
565 
782 
1,449 
1,358 
4,154 
122 
216 
405 
325 
1,068 
391 
1,117 
2,778 
2,712 
6,998 
18.8 (17.4, 20.2) 
14.9 (13.9, 15.8) 
13.2 (12.6, 13.9) 
11.4 (10.5, 11.9) 
13.3 (13.0, 13.7) 
04.1 (3.3, 4.8) 
04.1 (3.6, 4.7) 
03.7 (3.3, 4.0) 
02.7 (2.5, 3.0) 
03.4 (3.2, 3.7) 
13.0 (11.8, 14.2) 
21.3 (20.3, 22.3) 
25.2 (24.4, 26.0) 
22.7 (22.0, 23.5) 
22.4 (21.9, 22.9) 
319 
377 
726 
678 
2,100 
76 
125 
261 
209 
671 
242 
659 
1,621 
1,630 
4,152 
20.0 (18.1, 22.0) 
14.2 (12.9, 15.6) 
12.9 (12.0, 13.8) 
11.2 (10.4, 12.0) 
13.2 (12.7, 13.7) 
4.8 (3.7, 5.8) 
4.7 (3.9, 5.5) 
4.6 (4.1, 5.2) 
3.5 (3.0, 3.9) 
4.2 (3.9, 4.5) 
15.2 (13.4, 17.0) 
24.9 (23.3, 26.6) 
28.8 (27.6, 30.0) 
27.0 (25.8, 28.1) 
26.1 (25.4, 26.8) 
246 
405 
723 
680 
2,054 
46 
91 
144 
116 
397 
149 
458 
1,157 
1,082 
2,846 
17.8 (15.8, 19.8) 
16.0 (14.6, 17.4) 
13.8 (12.9, 14.7) 
11.8 (11.1, 12.8) 
13.8 (13.3, 14.4) 
03.3 (2.4, 4.2) 
03.5 (2.8, 4.3) 
02.7 (2.2, 3.2) 
02.0 (1.6, 2.4) 
02.6 (2.4, 4.2) 
10.5 (9.1, 12.1) 
17.5 (16.3, 19.3) 
21.5 (20.8, 23.0) 
18.4 (17.7, 19.8) 
18.6 (18.3, 19.6) 
579 
1,039 
1,845 
1,725 
5,187 
497 
515 
722 
642 
2,376 
857 
2,000 
4,242 
4,276 
11,375 
19.3 (17.8, 20.6) 
19.7 (18.6, 20.8) 
16.7 (16.0, 17.5) 
14.5 (13.9, 15.2) 
16.6 (16.3, 17.0) 
16.5 (15.3, 17.9) 
09.8 (9.1, 10.6) 
06.5 (6.1, 7.0) 
05.4 (5.0, 5.8) 
07.6 (7.3, 8.0) 
28.5 (26.9, 30.2) 
38.0 (36.8, 39.3) 
38.5 (37.6, 39.3) 
35.9 (35.0, 36.7) 
36.5 (36.0, 31.5) 
CI, confidence interval.to 9 years of age, and 10 to 13 years of age, respectively) and
was highest in male children between 7 and 9 years of age
(42.8%). In all the age groups, the prevalence in male
children was higher than in female children. The treatment
frequency for allergic rhinitis in the past 12 months was
22.4%. The treatment frequency was highest in children
between 7 and 9 years of age (25.2%). In all the age groups,
the treatment frequency was higher in male children than in
female children.
‘Symptom prevalence’ and ‘treatment frequency’ differ in
that some subjects who have symptoms are not medically
treated. The differences between these two groups were
3.3% for atopic dermatitis, 4.2% for asthma, and 14.1% for
allergic rhinitis. When comparing the differences according
to gender, there was a higher proportion of male children
compared to female children who were not medically treated
despite the appearance of symptoms. For atopic dermatitis,
the differences between these two groups were 3.0% for
male children and 2.6% for female children. For asthma, the
differences between symptom prevalence and treatment
frequency were 4.7% for male children and 3.4% for female
children. For allergic rhinitis, these differences were 14.5%
for male children and 12.2% for female children.
III. Prevalence of Comorbid Allergic Diseases 
In Table 4, the prevalence of comorbid allergic diseases is
presented. In instances where the patient had both atopic
dermatitis and asthma, the prevalence was 2.5% and was
highest in children between 0 and 3 years of age, with a
prevalence of 4.7% (5.7% in male children and 3.6% in
female children). By gender, 2.9% of male children and
2.1% of female children had symptoms of both atopic
dermatitis and asthma. The treatment frequency for both
atopic dermatitis and asthma was 0.9%. 
The prevalence of asthma and comorbid allergic rhinitis
was 4.7%. The prevalence in male children was 5.8%, while
the prevalence in female children was 3.6%. The prevalence
of these diseases was highest in children between 0 and 3
years of age at 7.4% (8.9% in male children and 5.7% in
female children). The treatment frequency for both asthma
and allergic rhinitis was 1.8%.
In situations where the patient had symptoms of both
atopic dermatitis and allergic rhinitis, the prevalence of
symptoms in the past 12 months was 8.7%. The prevalence
was highest in the 4- to 6-year-old age group, with a
prevalence of 10.2% (10.6% in male children and 9.8% in
female children). The treatment frequency for both atopic
dermatitis and allergic rhinitis was 4.5%. The proportion was
highest in the 7- to 9-year-old age group, with a prevalence of
5.2% (5.8% in male children and 4.6% in female children).
The prevalence of comorbid symptoms of atopic
dermatitis, asthma, and allergic rhinitis was 1.8% (highest in
0- to 3-year-old children, with a prevalence of 2.7%). The
highest prevalence rates observed were 3.5% in 0- to 3-year-
old male children and 2.0% in 4- to 6-year-old female
children. The treatment frequency for atopic dermatitis,
asthma, and allergic rhinitis was 0.6%. 
Using ‘symptoms in the past 12 months’ as the standard,
only 2,252 subjects (43.4%) experienced atopic dermatitis
symptoms, while the other subjects (56.6%) suffered from
asthma, allergic rhinitis or had both diseases with comorbid
atopic dermatitis (Figure 1). Of 2,376 subjects, 673 (28.3%)
had symptoms of asthma without an accompanying disease,
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Figure 1. Venn diagrams illustrating the associations
among the symptoms of atopic dermatitis, asthma, and
allergic rhinitis in the past 12 months. 
The size of the circles and overlapping areas are proportional with
respect to the total study population.
Figure 2. Venn diagrams illustrating the associations
among the treatment frequency for atopic dermatitis,
asthma, and allergic rhinitis in the past 12 months. 
The size of the circles and overlapping areas are proportional with
respect to the total study population.and 7,752 out of 11,375 subjects (68.1%) had symptoms of
allergic rhinitis without other allergic disease. 
Using ‘experience of treatment in the past 12 months’ as
the standard, 2,623 subjects (63.1%) received treatment for
atopic dermatitis alone without any accompanying
treatments (Figure 2). The remaining subjects (36.9%)
received treatment for asthma or allergic rhinitis or for both
diseases in addition to treatment for atopic dermatitis.
Similarly, 405 out of 1,086 subjects (37.9%) received
treatment for asthma only, and 5,211 out of 6,988 subjects
(78.4%) were treated for allergic rhinitis only.
DISCUSSION
This study aimed to analyze the prevalence of individual
and comorbid allergic diseases in children aged 0 to 13 years
who participated in a Seoul Atopy Friendly School survey.
Using ‘symptoms in the past 12 months’ as the standard, the
prevalence of atopic dermatitis was consistently high in
children less than 6 years of age, while the prevalence of
asthma and allergic rhinitis was highest in children 0 to 6
years of age and in children greater than 4 years old,
respectively. Male children had a higher prevalence of atopic
dermatitis, asthma, and allergic rhinitis than female children.
The prevalence of patients with both atopic dermatitis and
asthma, asthma and allergic rhinitis, or atopic dermatitis and
allergic rhinitis was 2.5%, 4.7%, and 8.7%, respectively. The
prevalence of having all three diseases was 1.8%. The
percentage of subjects who experienced at least one of the
many symptoms associated with at least one of the three
diseases in the past 12 months was 46.6%. For atopic
dermatitis and asthma, the prevalence of symptoms tended
to decrease as age increased. 
In Korea, several studies have been performed to evaluate
the prevalence of allergic diseases using the ISAAC
questionnaire [4,11,12]. Based on the data obtained from 3
rd,
4
th, and 5
th grade elementary school students, we compared
the results from previous studies [11] to our study. The
results of this comparison are as follows: the prevalence of
atopic dermatitis symptoms in the past 12 months in
previous studies and in our study was 15.3% vs. 16.7%,
respectively; the experience of treatment for atopic
dermatitis in the past 12 months was 13.7% vs. 13.1%,
respectively; the prevalence of asthma symptoms in the past
12 months was 4.8% vs. 6.3%, respectively; the experience
of treatment for asthma in the past 12 months was 2.5% vs.
3.3%, respectively; the prevalence of allergic rhinitis
symptoms in the past 12 months was 32.9% vs. 40.4%,
respectively; and the experience of treatment for allergic
rhinitis in the past 12 months was 21.3% vs. 26.1%,
respectively. For every condition evaluated, except for  the
experience of treatment for atopic dermatitis in the past 12
months, the prevalence observed in our study was higher
than in previous studies. This result may be because the
previous studies conducted by Suh et al. [11] targeted all the
provinces throughout the country, including the industrial
complex regions, whereas our research evaluated only
subjects living in Seoul. For example, there were significant
differences in the prevalence of atopic dermatitis symptoms
according to the area of residence (15.4% in the city, 13.6%
in the province, 11.4% in the countryside, and 15.9% in the
industrial complex).
It is well-known that the prevalence of atopic dermatitis,
asthma, and allergic rhinitis present with different
characteristics according to age, but few studies have
investigated the prevalence of allergic diseases throughout
childhood. When comparing this study to the study performed
in Beijing that studied children 0 to 14 years of age using the
ISAAC questionnaire, the rate of subjects with ‘symptoms in
the past 12 months’ with atopic dermatitis were high among
children 0 to 4 years of age [10]. However, as the subjects
aged, the prevalence showed a tendency to decrease
significantly. In our study, the prevalence of atopic dermatitis
was high among children 0 to 3 years of age and 4 to 6 years
of age, but the prevalence decreased as the subjects aged. The
prevalence of ‘symptoms in the past 12 months’ among
children with asthma in Beijing was highest for children
between 2 and 9 years of age, and the prevalence of
‘symptoms in the past 12 months’ among the subjects with
asthma in this study was highest for those between 0 and 6
years of age. Our study demonstrated a high prevalence of
asthma, especially for children between 1 and 3 years of age;
however, because wheezing and whistling sounds are
common at that age, it may have been difficult to differentiate
these sounds from asthma symptom sounds [16]. This
phenomenon, however, was not observed in the Beijing study,
and the authors suggested that this was due to the difference in
the way people answered the questions. In the Beijing study,
the prevalence of allergic rhinitis was highest in children
between 4 and 11 years of age [10], while in our study, the
prevalence increased as age increased. The above results
confirm the progression of allergies (such as atopic dermatitis,
asthma, and allergic rhinitis) in which the symptoms appear
either simultaneously or sequentially as time progresses [17].
To reduce the progression of allergic diseases, management
policies that consider the differences in the prevalence of the
disease according to age must be established.
Our study demonstrated that, with the exception of two or
three different age groups, asthma and rhinitis have a higher
prevalence among male children than female children. These
results support the results obtained from previous studies
[10,11,18,19]. A previous study suggested that the cycling of
sex hormones according to gender and age may influence
the prevalence of asthma in males more so than in females
before puberty, but this phenomenon reversed as the subjects
went through puberty [20]. In a cohort study in Finland, the
prevalence of asthma was higher in male children than in
Environmental Health and Toxicology 2012;27:e2012006
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prevalence was the same for both genders [21]. In an animal
experiment, the female sex hormone progesterone was
shown to have the greatest effect on the prevalence of
asthma according to gender, and an even higher effect was
observed when the subject smoked [22].
Allergic diseases such as atopic dermatitis, asthma, and
allergic rhinitis often appear sequentially according to age,
though many symptoms occasionally appear at the same
time [23]. This indicates that asthma and allergic rhinitis
share a similar pathological mechanism and that clinical
expression occurs on the upper or lower side of the
respiratory organs [24,25].
Based on British research, the prevalence of multiple
allergic diseases is 11% for children between the ages of 2
and 15 years, 10% for individuals between the ages of 16
and 44 years, and 5% for people over the age of 45. The
prevalence observed in subjects between 2 and 15 years of
age who were diagnosed with asthma, dermatitis, and
rhinitis was 2% [7]. From Britain s primary care database,
which contains information on the prevalence of 2 or more
allergic diseases between 0 and 90 years of age, the
prevalence was highest among those between 10 and 14
years of age. After this age, the prevalence decreases as age
increases [26]. However, this study analyzed only the
number of allergic diseases and did not take into account the
effects caused by different types of diseases.
In addition to the reasons suggested in previous studies
with respect to the comorbidity of allergic disease, other
possible explanations include a fillagrin mutation (one of the
factors that cause atopic dermatitis and asthma) or the
occurrence of food allergies [27]. Fillagrin is a substrate
protein located underneath the stratum corneum that protects
the skin from the environment. Genetic mutations of fillagrin
are known to increase the occurrence of allergization, atopic
dermatitis, allergic rhinitis, and asthma in a person with a
skin disease [28]. In addition, a modification of fillagrin
leads to a weakening of the skin wall, which, at a young age,
presents as dermatitis and then later becomes a risk factor for
asthma [29,30].
The strength of this research is that it is the first study
conducted in Korea to examine the prevalence of individual
allergic diseases and multiple allergic diseases in subjects
between 0 and 13 years of age. Previous studies have only
investigated elementary school aged children or a few age
groups at different ages. However, this research simul-
taneously investigated children between 0 and 13 years of
age. Furthermore, previous studies have only examined the
prevalence of individual allergic diseases, but because there
has been no research on children between 0 and 6 years of
age, it has been difficult to explain the progression of allergic
diseases in young children.
An additional strength of this research is that the use of the
ISAAC questionnaire has made it possible to compare the
results of this study to the prevalence of allergic diseases in
other countries. In the ISAAC study, a phase III
investigation was performed with 5 to 10 year intervals after
the initial investigation. According to the results from 143
centers, 60 countries, and 385,853 children between 6 and 7
years of age who participated in the phase III ISAAC
research, the prevalence of atopic dermatitis symptoms in
the previous 12 months ranged from 0.9% to 22.6%. In our
study, the prevalence for the same age group and the same
symptoms was 17.9%, a prevalence that ranked 5th out of 60
countries [15]. The prevalence of asthma symptoms in the
past 12 months for children between 6 and 7 years of age in
our study was 8.1%. Compared to the prevalence of asthma
for the same age group according to the ISAAC study,
which included subjects from 66 centers in 34 countries, our
study ranked 26
th out of 37 countries, indicating that the
prevalence of asthma was relatively low in our study [31].
The prevalence of allergic rhinitis symptoms in the past 12
months in our study was 38.9%, which was much higher
than the global average of 20.7%. Out of 66 centers, only 4
centers reported a prevalence of allergic rhinitis symptoms in
the past 12 months higher than 30%: Fukuoka (Japan),
Taipei (Taiwan), Bangkok (Thailand), and Costa Rica.
The weakness of this study is that disease severity, the
period of disease contraction, the family history of disease,
and lifestyle were not analyzed. Furthermore, there may be
some problems with respect to representativeness because
the procedure used to enroll institutions did not adhere to the
probability sampling process. However, because all of the 25
districts in Seoul participated in this study, and the
elementary schools and children’s daycare centers that
participated were equally distributed throughout the 5 larger
areas, it is believed that the prevalence obtained from this
study may reflect the prevalence throughout Seoul. The
prevalence obtained from this study tended to be higher than
that obtained in previous studies. This may be due to
increases in the prevalence of allergic diseases. However, it
is predicted that environment and lifestyle could have
contributed to this increase, and therefore, in the future, this
possibility must be investigated.
The results of this study demonstrate the prevalence of
allergic diseases in children from Seoul. This study
investigated not only individual allergic diseases but also
comorbid allergic diseases that manifest at similar times
according to age groups. This information is pertinent for the
development of a treatment regimen for allergic diseases.
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